Resistance Training and Cardiometabolic Risk - Trial NCT06054594
Access comprehensive clinical trial information for NCT06054594 through Pure Global AI's free database. This phase not specified trial is sponsored by Université du Québec a Montréal and is currently Completed. The study focuses on Metabolic Syndrome. Target enrollment is 51 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Université du Québec a Montréal
Timeline & Enrollment
N/A
Jan 01, 2009
Jun 09, 2011
Primary Outcome
Insulin resistance (IR)
Summary
Little is known on the effects of resistance training (RT) alone in individuals with
 metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUHO). The present
 study aimed to examine the impact of RT on body composition, physical performance,
 lipid-lipoprotein profile, inflammation, and glucose-insulin homeostasis in 51 sedentary,
 postmenopausal women categorized as MHO vs MUHO, according to the Karelis and Rabasa- Lhoret
 classification or a single-phenotype adiposopathy approach (the plasma adiponectin (A)/leptin
 (L) ratio). Participants followed a 4-month weekly RT program of 3 non-consecutive days of 6
 exercises of major muscle groups (3 sets of 10 repetitions at 80% 1-RM).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06054594
Non-Device Trial